Your browser doesn't support javascript.
Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021.
Houhamdi, Linda; Gautret, Philippe; Hoang, Van Thuan; Fournier, Pierre-Edouard; Colson, Philippe; Raoult, Didier.
  • Houhamdi L; Department of Microbiology, IHU-Méditerranée Infection. Assistance Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Gautret P; Department of Microbiology, IHU-Méditerranée Infection. Assistance Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Hoang VT; Institut de Recherche pour le Développement (IDR), AP-HM, SSA, VITROME, Aix-Marseille Université, Marseille, France.
  • Fournier PE; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
  • Colson P; Department of Microbiology, IHU-Méditerranée Infection. Assistance Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Raoult D; Institut de Recherche pour le Développement (IDR), AP-HM, SSA, VITROME, Aix-Marseille Université, Marseille, France.
J Med Virol ; 94(5): 2290-2295, 2022 05.
Article in English | MEDLINE | ID: covidwho-1777588
ABSTRACT
One thousand one hundred and nineteen cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant cases have been diagnosed at the Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France, between November 28, 2021, and December 31, 2021. Among the 825 patients with known vaccination status, 383 (46.4%) were vaccinated, of whom 91.9% had received at least two doses of the vaccine. Interestingly, 26.3% of cases developed SARS-CoV-2 infection within 21 days following the last dose of vaccine suggesting possible early production of anti-SARS-CoV-2 facilitating antibodies. Twenty-one patients have been hospitalized, one patient required intensive care, and another patient who received a vaccine booster dose died.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27613

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27613